Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 29,491 |
|
|||||
| News | - | ||||||
| Day High | 1.581 | Low High |
|||||
| Day Low | 1.50 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cocrystal Pharma Inc | COCP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.045 | 2.98% | 1.555 | 17:16:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.52 | 1.50 | 1.581 | 1.555 | 1.51 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 74 | 29,491 | $ 1.55 | $ 45,801 | - | 1.325 - 3.285 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:19:56 | 1 | $ 1.485 | USD |
Cocrystal Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 15.77M | 10.17M | - | 2.6M | -17.98M | -1.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cocrystal Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COCP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.48 | 1.5999 | 1.48 | 1.53 | 4,719 | 0.075 | 5.07% |
| 1 Month | 1.50 | 1.67 | 1.35 | 1.51 | 13,994 | 0.055 | 3.67% |
| 3 Months | 1.59 | 1.74 | 1.325 | 1.49 | 13,735 | -0.035 | -2.20% |
| 6 Months | 1.65 | 1.99 | 1.325 | 1.63 | 16,118 | -0.095 | -5.76% |
| 1 Year | 2.45 | 3.285 | 1.325 | 2.19 | 23,040 | -0.895 | -36.53% |
| 3 Years | 15.36 | 41.52 | 1.325 | 19.16 | 1,832,123 | -13.81 | -89.88% |
| 5 Years | 32.04 | 49.20 | 1.325 | 18.89 | 2,024,409 | -30.49 | -95.15% |
Cocrystal Pharma Description
| Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). |
